Journal of Clinical Laboratory Analysis

Papers
(The H4-Index of Journal of Clinical Laboratory Analysis is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace251
Bacteriocins: Properties and potential use as antimicrobials158
Translation role of circRNAs in cancers87
Obesity and gut–microbiota–brain axis: A narrative review73
Analysis of COVID‐19 vaccines: Types, thoughts, and application71
Systemic immune‐inflammation index is associated with disease activity in patients with ankylosing spondylitis66
The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway60
Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls54
An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines47
Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer41
Hematological changes associated with COVID‐19 infection39
Mechanism of action, resistance, synergism, and clinical implications of azithromycin37
Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study35
Associations between hematological parameters and disease severity in patients with SARS‐CoV‐2 infection35
COVID‐19 spreading across world correlates with C677T allele of the methylenetetrahydrofolate reductase (MTHFR) gene prevalence34
Malaria diagnostic update: From conventional to advanced method33
The diagnostic protocol for hereditary spherocytosis‐2021 update32
Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment32
Nucleocapsid protein of SARS‐CoV‐2 is a potential target for developing new generation of vaccine32
To handle the inflation of odds ratios in a retrospective study with a profile penalized log‐likelihood approach28
Worldwide prevalence of microbial agents’ coinfection among COVID‐19 patients: A comprehensive updated systematic review and meta‐analysis28
N‐6 methylation‐related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment28
Circular RNA circβ‐catenin aggravates the malignant phenotype of non‐small‐cell lung cancer via encoding a peptide27
Evaluation of hematological parameters as an indicator of disease severity in Covid‐19 patients: Pakistan's experience27
Early diagnosis of breast cancer from exhaled breath by gas chromatography‐mass spectrometry (GC/MS) analysis: A prospective cohort study27
Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma27
Red blood cell distribution width‐to‐albumin ratio is associated with all‐cause mortality in cancer patients26
Neurological manifestations in patients with COVID‐19: A systematic review and meta‐analysis26
Elevated AST/ALT ratio is associated with all‐cause mortality and cancer incident26
Peripheral blood inflammatory markers in predicting prognosis in patients with COVID‐19. Some differences with influenza A26
0.04920506477356